Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Total Non-Current Liabilities (2023 - 2025)

Historic Total Non-Current Liabilities for Profound Medical (PROF) over the last 3 years, with Q3 2025 value amounting to $10.1 million.

  • Profound Medical's Total Non-Current Liabilities fell 914.33% to $10.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.1 million, marking a year-over-year decrease of 914.33%. This contributed to the annual value of $9.7 million for FY2024, which is 2305.08% down from last year.
  • Per Profound Medical's latest filing, its Total Non-Current Liabilities stood at $10.1 million for Q3 2025, which was down 914.33% from $10.3 million recorded in Q2 2025.
  • Profound Medical's Total Non-Current Liabilities' 5-year high stood at $12.7 million during Q4 2023, with a 5-year trough of $9.7 million in Q4 2024.
  • Over the past 3 years, Profound Medical's median Total Non-Current Liabilities value was $10.5 million (recorded in 2024), while the average stood at $10.8 million.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 2305.08% in 2024, then plummeted by 364.64% in 2025.
  • Over the past 3 years, Profound Medical's Total Non-Current Liabilities (Quarter) stood at $12.7 million in 2023, then fell by 23.05% to $9.7 million in 2024, then increased by 3.54% to $10.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $10.1 million for Q3 2025, versus $10.3 million for Q2 2025 and $10.0 million for Q1 2025.